Bionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple Myeloma
23 juil. 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, July 23, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of the first multi-site study in multiple myeloma (MM) comparing optical genome...